Seattle, WA -- (SBWire) -- 11/06/2019 --Increasing consumption of livestock products such as meat, milk, and other animal food products is expected to propel growth of the veterinary antibiotics market. Increasing prevalence of various diseases in livestock is also expected to contribute to the market growth. For instance, according to the United Nations 2015 report, antibiotics consumption in livestock is expected to reach 105,600 tons by 2030, globally due to increase in the number of animals raised for food production.

Veterinary antibiotics are used in the treatment of infections caused by bacteria and in therapeutic and prophylaxis or preventative treatment against other diseases in livestock. Antibiotics also promote growth in herds or flocks. Antibiotics are available in powder and tablet form and are fed to animals to enhance livestock production and nutritional level.

Get a PDF Sample of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/2324

Farmers are increasing using antibiotics to optimize production of animal protein, which further aids in growth of the market. According to the Organization for Economic Co-operation and Development (OECD) 2015 data, with increase in human population and increased demand for meat, estimated antibiotic use in food animals will increase by 67% globally from 2010 to 2030.

High use of antibiotics can lead to antibiotic-resistance and other side effects in animals and make them ineffective in treatment of various infections, which is expected to hinder growth of the market. Moreover, stringent government regulations for antibiotics use is also expected to restrict the market growth during the forecast period. For instance, according to the new guidelines published by the World Health Organization (WHO), in 2017, the farmers and the food industry are recommended to stop using antibiotics routinely to promote growth and prevent disease in healthy animals.

Moreover, increasing preference for organic livestock, owing to growing health concerns is also expected to hinder the market growth. For instance, according to the U.S. Department of Agriculture National Agricultural Statistics Service (USDA NASS), the U.S. organic broiler chicken inventories grew 145% by 2016.

Request for Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/2324

On the basis of region, the global veterinary antibiotics market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America accounted for the largest revenue share in the global veterinary antibiotics market in 2017, owing to factors such as increasing animal farming, high investment in animal healthcare, and growing demand for animal-derivative food products. For instance, according to the U.S. FDA 2014 report, of all antibiotics sold in the U.S., around 80% were sold for use in animal agriculture. As per the same source, in the U.S., the total amount of antibiotics used in food-producing animals increased by 16% between 2009 and 2012, to 14.61 million kilograms per year.

According to the study published in PLOS Journal in 2016, the national diet of India has radically changed, with increased meat consumption among the young urban generation. Growing demand for animal proteins has resulted in intensive breeding of fish, poultry, and pigs with the routine use of antibiotics as growth promoters. Moreover, according to the Organization for Economic Co-operation and Development (OECD), China is the major producer of pork meat with around 31.3 kg/capita pork meat produced in 2016, followed by poultry and beef.

Key players operating in the global veterinary antibiotics market include, Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Crystal Pharma, Dechra Pharmaceuticals PLC, Huvepharma AD, Eli Lilly Company, Elanco, Merck & Co., Inc., Sanofi, Vetoquinol S.A., Virbac, and Zoetis, Inc.

Inquire about Discount on this Report @ https://www.coherentmarketinsights.com/insight/request-discount/2324